MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 179 filers reported holding MIRATI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,876,250 | +0.1% | 83,000 | -25.8% | 0.00% | 0.0% |
Q3 2023 | $4,870,008 | +52.1% | 111,800 | +26.2% | 0.00% | +100.0% |
Q2 2023 | $3,201,118 | -1.0% | 88,600 | +1.8% | 0.00% | 0.0% |
Q1 2023 | $3,234,660 | -24.1% | 87,000 | -7.4% | 0.00% | -33.3% |
Q4 2022 | $4,259,140 | -33.9% | 94,000 | +2.0% | 0.00% | -40.0% |
Q3 2022 | $6,439,000 | +5.1% | 92,200 | +1.0% | 0.01% | +25.0% |
Q2 2022 | $6,129,000 | -18.4% | 91,300 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $7,507,000 | -35.6% | 91,300 | +14.8% | 0.00% | -42.9% |
Q4 2021 | $11,662,000 | -17.2% | 79,500 | -0.1% | 0.01% | -22.2% |
Q3 2021 | $14,082,000 | +11.6% | 79,600 | +1.9% | 0.01% | +12.5% |
Q2 2021 | $12,615,000 | -8.4% | 78,100 | -2.9% | 0.01% | -11.1% |
Q1 2021 | $13,773,000 | -4.3% | 80,400 | +22.7% | 0.01% | -10.0% |
Q4 2020 | $14,386,000 | +34.7% | 65,500 | +1.9% | 0.01% | +25.0% |
Q3 2020 | $10,677,000 | +48.2% | 64,300 | +1.9% | 0.01% | +33.3% |
Q2 2020 | $7,204,000 | +88.6% | 63,100 | +27.0% | 0.01% | +50.0% |
Q1 2020 | $3,820,000 | -39.4% | 49,700 | +1.6% | 0.00% | -33.3% |
Q4 2019 | $6,301,000 | +84.2% | 48,900 | +11.4% | 0.01% | +50.0% |
Q3 2019 | $3,420,000 | -22.2% | 43,900 | +2.8% | 0.00% | -20.0% |
Q2 2019 | $4,398,000 | +68.6% | 42,700 | +19.9% | 0.01% | +66.7% |
Q1 2019 | $2,609,000 | +79.3% | 35,600 | +3.8% | 0.00% | +50.0% |
Q4 2018 | $1,455,000 | +2.0% | 34,300 | +13.2% | 0.00% | 0.0% |
Q3 2018 | $1,427,000 | -4.5% | 30,300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,494,000 | +974.8% | 30,300 | +44.3% | 0.00% | – |
Q3 2016 | $139,000 | +20.9% | 21,000 | 0.0% | 0.00% | – |
Q2 2016 | $115,000 | -73.5% | 21,000 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $434,000 | -14.7% | 21,000 | +30.4% | 0.00% | 0.0% |
Q4 2015 | $509,000 | -8.1% | 16,100 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $554,000 | +104.4% | 16,100 | +87.2% | 0.00% | 0.0% |
Q2 2015 | $271,000 | – | 8,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $257,839,000 | 68.01% |
Boxer Capital, LLC | 2,000,000 | $164,440,000 | 8.45% |
Avoro Capital Advisors LLC | 5,325,000 | $437,822,000 | 7.99% |
M28 Capital Management LP | 82,900 | $6,816,000 | 6.27% |
Artal Group S.A. | 1,350,000 | $110,997,000 | 4.65% |
Nextech Invest Ltd. | 173,300 | $14,249,000 | 4.07% |
Perceptive Advisors | 2,380,710 | $195,742,000 | 3.92% |
Logos Global Management LP | 350,000 | $28,777,000 | 3.73% |
Camber Capital Management LP | 1,200,000 | $98,664,000 | 3.57% |
RTW INVESTMENTS, LP | 1,561,497 | $128,386,000 | 2.66% |